HFNC vs Microstream nasal cannula during ERCP
Official title: HFNC Versus Microstream Advance Nasal Cannula for Oxygenation During ERCP
Run by Kocaeli University · NCT07611903 · Data updated 2026-11-12
This study compares high-flow nasal oxygen with the Microstream Advance nasal cannula to see which one better keeps patients’ oxygen levels stable during ERCP procedures done under deep sedation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 84 Years |
| Sex | All |
| Enrollment | 74 (estimated) |
| Sponsor | Kocaeli University Academic / other |
| Locations | 1 site (Kocaeli, Umuttepe) |
| Status | Recruiting |
| Started | July 14, 2026 |
| Main results expected | November 30, 2026 |
| Study ends | December 30, 2026 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07611903 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–84 years old with ASA I–III undergoing ERCP, without recent upper respiratory infection, COPD, asthma, lung cancer, BMI >35, and who consent to participate.
✕Probably not a fit
Patients with severe oxygenation issues beyond the scope of standard support or those not responding to either device may gain no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective randomized trial tests two oxygen delivery methods during ERCP procedures: high-flow nasal cannula (HFNC) and the Microstream Advance nasal cannula. Participants are adults with ASA I–III scheduled for ERCP and randomized to receive oxygen support with one of the two devices while sedated. Primary outcomes include rate of desaturation and oxygen reserve index during the procedure; secondary outcomes cover time to reach target ORi, respiratory complications, and procedure-related adverse events. The study is conducted at a single center, with Kocaeli University as the lead sponsor. Enrollment targets adults aged 18 to 84 without active lung disease or BMI >35 kg/m², and who provide informed consent.
Why it matters
Potential benefit: If successful, the preferred oxygen delivery method could reduce hypoxemia during ERCP and improve patient safety.
How similar studies have gone: Past studies in other procedures suggest oxygen delivery methods can impact oxygenation, but direct evidence for this comparison in ERCP is limited, making results informative though not guaranteed.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients aged 18 to 84 years * ASA physical status I-III * Patients scheduled to undergo ERCP * Patients who provide written informed consent Exclusion Criteria: * Recent history of upper respiratory tract infection * History of lung cancer * Chronic obstructive pulmonary disease * Asthma * Body mass index greater than 35 kg/m² * Refusal to participate in the study
Where it's running
-
Kocaeli University Faculty of Medicine Hospital
Kocaeli, Umuttepe, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Volkan Alparslan, M.D. — Kocaeli University
- Study coordinator: Volkan Alparslan, M.D.
- Email: volknn@hotmail.com
- Phone: 05059374578
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Melanin-Adjusted Blood Oxygen Sensor in ICU Patients
This study tests a new pulse oximeter that adjusts for skin pigment to see if it gives accurate oxygen readings in ICU patients.
-
HFNO vs. face mask for cerebral oxygenation during procedural sedation
This randomized trial tests whether high-flow nasal oxygen helps maintain brain oxygenation better than a standard face mask during procedures done with sedation in adults.
-
Extra oxygen during the 6-minute walk for people with chronic respiratory failure or exercise-related low oxygen
This trial will test whether giving extra oxygen during a 6-minute walk helps people with chronic respiratory failure or exertional low oxygen from COPD or interstitial lung disease walk farther, breathe better, and feel easier during the test.
-
Safety and performance of the INBENTUS VERSATILE ventilator in adults on invasive mechanical ventilation
This trial will test whether the INBENTUS VERSATILE ventilator is safe and performs well in adults who need assisted or controlled invasive mechanical ventilation and short-term weaning.
-
PIMUN to reduce low-oxygen episodes in preterm infants
We will test whether PIMUN, a soft garment that gives gentle pulsatile dorsal stimulation, can reduce low-oxygen (SpO2 <90%) episodes in preterm infants born at 24–34 weeks who have apnea of prematurity.
-
COMBO airway plus high-flow nasal oxygen during sedated gastrointestinal endoscopy for morbidly obese adults
This test will try combining the COMBO Endoscopy oropharyngeal airway with high-flow nasal oxygen to see if it reduces low-oxygen episodes during sedated gastrointestinal endoscopy in adults with BMI 35 or higher.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.